
1. Technology overview
Remi Health GmbH is a Berlin-based company that offers a Diagnostics-as-a-Service platform for European healthcare. Payers, digital health companies, pharma, longevity programs and clinics use it to embed diagnostic testing into their products through one integration. The legal notice lists its address at Knesebeckstraße 33-34, 10623 Berlin.
The platform covers sample collection, kit logistics, routing across partner laboratories, medical validation and digital delivery of results. Collection options include at-home capillary sampling, dry blood spot and venous draws via partner clinics. It is offered as a white-label journey or through an API with OAuth2, signed webhooks and endpoints for orders and results. It is live in Germany, Austria and Switzerland.
2. Highlighted features & specifications
- Sample collection: at-home capillary sampling, dry blood spot and venous draws via partner clinics.
- Sample logistics: kit transport and routing across partner labs with medical validation.
- Results delivery: digital results with reference ranges, trends and physician review.
- Developer API: OAuth2 client credentials, signed webhooks and endpoints for orders, phlebotomy, lab orders and results.
- Test catalog: metabolic, hormone, vitamin, infectious disease and cancer screening panels.
- Deployment options: white-label journey hosted by Remi or build-your-own integration.
3. Potential application
Vietnamese health insurers could embed preventive blood testing as a member benefit through an API. Telehealth and wellness platforms could add at-home sample collection with physician-reviewed results.
4. Benefits
One API and one contract cover sample collection, lab routing and results, which removes the need to build separate lab partnerships. The company reports over 1 million diagnostic tests processed. Partner laboratories hold ISO 15189 accreditation and hosting is in certified German infrastructure. Results include reference ranges, trends and physician review.
5. Market trends & opportunities
Payers, pharma and digital health companies are adding at-home and prevention testing but face fragmented lab and logistics partners. Funding coverage describes an open diagnostics network as the company's next step. Vietnamese insurers, telehealth apps and wellness brands exploring at-home testing face the same operational complexity.
6. Other information
Remi Health GmbH, Knesebeckstraße 33-34, 10623 Berlin, HRB 285877 B. Seed of 3 million EUR in March 2026 led by IBB Ventures with Catalpa Ventures and MSD Global Health Innovation Fund, bringing total funding to 5 million EUR.
One platform connecting startups, corporations, research institutions, regions and investors











Playbook & Handbook · February 6, 2026
Winning Accelerator Playbook 2026 by BambuUP
RETAIL E-COMMERCE: AI AND REAL-TIME DATA ARE TRANSFORMING HOW RETAIL BUSINESSES OPERATE








































